Why Recursion Pharmaceuticals Stock Is Up Today
Key PointsOne of Recursion Pharmaceuticals’ internally developed drugs is advancing to late-stage clinical trials.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.